ASPEK HISTOPATOLOGIK LIPOSARKOMA
Abstract
Liposarcoma is a malignancy that comes from primitive cells that have differentiation into fat cells. Location of the tumor is usually in the extremities, trunk and retroperitoneum. Liposarcoma is slow growing, deep, painless and large in size. Most sufferers are adults, aged between 40-60 years, a little dominant in men. In children, it tends to occur in the second decade of life. The incidence of liposarcoma in the world is 17% of all soft tissue malignancies. Data in the RSCM shows 70 cases of liposarcoma in a period of 10 years. The etiology of liposarcoma can come from physical factors, chemistry and biology that can be carcinogens in addition to genetic factors as a predisposition to liposarcoma. The diagnosis of liposarcoma is based on history taking and physical examination which begins with complaints of large pains that are painless and grow slowly, supported by radiological and histopathological examination as a determinant of diagnosis. Histopathological features of liposarcoma form the basis of classification, divided into five categories, namely: (1) well differentiated liposarcoma, (2) dedifferentiated liposarcoma, (3) mycid liposarcoma, (4) round cell liposarcoma, (5) pleomorphic liposarcoma. Liposarcoma management in the form of multimodality therapy, a combination of surgery, radiotherapy and chemotherapy. The prognosis of liposarcoma is mainly determined by the histopathologic type, tumor location and tumor size.
Metrics
References
2. Schwartz RA. Liposarcoma. Medscape Reference Drugs, Diseases & Procedures, diunduh dari http://emedicine.medscaspe.com/article/1102007-overview (update: 13 Mei, 2011), 22 Des 2011.
3. Pedeutour F, Dei Tos AP, Antonescu C, Ladanyi M, Mentzel T. Adipocytic tumors. In: Christopher DMF, Krishnan KU, Fedrick M, editors. World health classification of tumours, pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. p. 35-45.
4. Mentzel T, Palmedo G, Kuhnen C. Well differentiated spindle cell liposarcoma (atypical spindle cell lipomatous tumor) does not belong to the spectrum of atypical lipomatous tumor but has a close relationship to spindle cell lipoma: clinicopathologic, immunohistochemical and molecular analysis of six cases. Mod Pathol. 2010; 23:729-36.
5. Kim HS, Lee J, Yi SY, Jun HJ, Choi YL, Ahn GH et al. Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy. BMC Cancer. 2009; 9:205.
6. Conyers R, Young S, Thomas DM. Liposarcoma: molecular genetics and therapeutics. Hindawi Publishing Corporation. 2011; 10:1155.
7. Downes KA, Golblum JR, Montgemery EA, Fisher C, Path FRC. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol. 2001; 14(3):179-184.
8. Kanwar VS. Pediatric liposarcoma. Medscape Reference Drugs, Diseases & Procedures, diunduh dari http://emedicine.medscaspe.com/article/987446-overview (update: 15 Februari 2011), 16 Januari 2011.
9. YCS Ng, MH Tan. Liposarcoma of the extremities: a review of the cases seen and managed in a major tertiary hospital in singapore. Singapore Med J. 2009; 50:857-61.
10. Weaver J, Rao P, Goldblum JR, Joyce MJ, Turner SL, Lazar AJF et al. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well differentiated liposarcoma. Mod Pathol. 2010; 23:1301-6.
11. Tuna B, Lebe B, Sis B, Yorukoglu K, Kargi A. Mdm2 gene expression in adipose-tissue tumors: association with tumor progression in liposarcomas. Aegean Pathol J. 2004; 1:11-8.
12. Liposarcoma, diunduh dari http://www.thedoctorsdoctor.com/diseases/liposarkoma.htm (updated: 3 Des 2007), 27 Des 2012.
13. Loubignac F, Bourtoul C, Chapel F. Myxoid liposarcoma : a rare soft tissue with a misleading benign appearance. World J Surg Oncol. 2009; 7:42.
14. Khan AN. Liposarcoma imaging. Medscape Reference Drugs, Diseases & Procedures, diunduh dari http://emedicine.medscaspe.com/article/391272-overview (update: 27 Mei, 2011), 16 Jan 2012.
15. Knight JA, White-Ryan W. Soft-tissue liposarcoma. Salem Heath Cancer. 2008;4:1408.
16. Hanna SA, Qureshi YA, Bayliss L, David LA, O’Donnell P, Judson IR et al. Late widespread skeletal metastases from myxoid liposarcoma detected by MRI only. World J Surg Oncol. 2008; 6:62.
17. Binh MBN, Garau XS, Guillou L, Aurias A, Coindre JM. Reproducibility of MDM2 and CDK4 staining in soft tissue tumors. Am J Clin Pathol. 2006; 125:693-7.
18. Hatano H, Morita T, Ogose A, Hotta T, Kobayashi H, Honma K. Well differentiated liposarcoma associated with benign lipoma. Anticancer Res. 2004; 24:1039-44.
19. Teo Eu-Leong H. Musculoskeletal tumor imaging for staging and treatment planning. Medscape Reference Drugs, Diseases & Procedures, diunduh dari http://emedicine.medscaspe.com/article/399175-overview (update: 11 April, 2011), 16 Jan 2011.
20. Rouse RV. Myxoid liposarcoma, diunduh dari http://surgpathcriteria.stanford.edu/softfat/myxoid_liposarcoma/differentialdiagnosis.html (update: 8 mei 2011), 15 Jan 2012.
21. Brcic L, Jakovcevic A, Vuletic LB, Orlic DSS. Pleomorphic liposarcoma of the foot: a case report. Diagnostic Pathol. 2008; 3:15.
22. Weaver J, Downs-Kelly E, Goldblum JR, Turner S, Kulkarni S, Tubbs RR et al. Flourecence in situ hybridization for MDM2 gene amplification as s diagnostic tool in lipomatous neoplasm. Mod Pathol. 2008; 21:943-9.
